Fleming, Thomas R.

Prevention of HIV-1 infection with early antiretroviral therapy.

Cohen, M. S., Chen, Y. Q., McCauley, M., Gamble, T., Hosseinipour, M. C., Kumarasamy, N., Hakim, J. G., Kumwenda, J., Grinsztejn, B., Pilotto, J. H. S., et al. (2011) · New England Journal of Medicine

HIV/AIDS Research and InterventionsHIV Research and Treatment

Cited by 6,873

A Multiple Testing Procedure for Clinical Trials

O'Brien, P. C., & Fleming, T. R. (1979) · Biometrics

Statistical Methods in Clinical TrialsProbability and Statistical Research

Cited by 3,311

Antiretroviral therapy for the prevention of HIV-1 transmission.

Cohen, M. S., Chen, Y. Q., McCauley, M., Gamble, T., Hosseinipour, M. C., Kumarasamy, N., Hakim, J. G., Kumwenda, J., Grinsztejn, B., Pilotto, J. H. S., et al. (2016) · New England Journal of Medicine

HIV/AIDS Research and InterventionsHIV Research and Treatment

Cited by 1,700

Surrogate End Points in Clinical Trials: Are We Being Misled?

Fleming, T. R., & DeMets, D. L. (1996) · Annals of Internal Medicine

Statistical Methods in Clinical TrialsAdvanced Causal Inference Techniques

Cited by 1,651

Targeted Anticytokine Therapy in Patients With Chronic Heart Failure: Results of the Randomized Etanercept Worldwide Evaluation (RENEWAL)

Mann, D. L., McMurray, J. J. V., Packer, M., Swedberg, K., Borer, J. S., Colucci, W. S., Djian, J., Drexler, H., Feldman, A., Kober, L., et al. (2004) · Circulation

Heart Failure Treatment and ManagementCardiac Fibrosis and Remodeling

Cited by 1,240

Prognosis in primary biliary cirrhosis: Model for decision making

Dickson, R. E., Grambsch, P. M., Fleming, T. R., Fisher, L. D., & Langworthy, A. (1989) · Hepatology

Liver Diseases and ImmunityLiver Disease and Transplantation

Cited by 816

High-Dose Vitamin C versus Placebo in the Treatment of Patients with Advanced Cancer Who Have Had No Prior Chemotherapy: A Randomized Double-Blind Comparison

Moertel, C. G., Fleming, T. R., Creagan, E. T., Rubin, J., O'Connell, M. J., & Ames, M. M. (1985) · New England Journal of Medicine

Vitamin C and Antioxidants ResearchComplementary and Alternative Medicine Studies

Cited by 637

Idiopathic Pulmonary Fibrosis: Clinically Meaningful Primary Endpoints in Phase 3 Clinical Trials

Raghu, G., Collard, H. R., Anstrom, K. J., Flaherty, K. R., Fleming, T. R., King, T. E., Martinez, F. J., & Brown, K. K. (2012) · American Journal of Respiratory and Critical Care Medicine

Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisStatistical Methods in Clinical Trials

Cited by 242

Discussion: The Role, Position, and Function of the FDA—The Past, Present, and Future

Fleming, T. R., Demets, D. L., & McShane, L. M. (2017) · Biostatistics

Statistical Methods in Clinical TrialsHealthcare Regulation

Cited by 13